Joseph H. Schwab

ORCID: 0000-0003-1156-3864
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sarcoma Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Management of metastatic bone disease
  • Oral and Maxillofacial Pathology
  • Spine and Intervertebral Disc Pathology
  • Infectious Diseases and Tuberculosis
  • Spinal Fractures and Fixation Techniques
  • Musculoskeletal synovial abnormalities and treatments
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Orthopaedic implants and arthroplasty
  • Orthopedic Infections and Treatments
  • Protein Degradation and Inhibitors
  • Cancer Immunotherapy and Biomarkers
  • Pelvic and Acetabular Injuries
  • Amoebic Infections and Treatments
  • Spinal Dysraphism and Malformations
  • Cancer Diagnosis and Treatment
  • Bone health and treatments
  • Cancer-related Molecular Pathways
  • Total Knee Arthroplasty Outcomes
  • Medical Imaging and Analysis
  • Tumors and Oncological Cases
  • Bone and Joint Diseases
  • Shoulder and Clavicle Injuries

Harvard University
2015-2025

Massachusetts General Hospital
2016-2025

Cedars-Sinai Medical Center
2024-2025

Universitätsmedizin Göttingen
2025

Boston University
2022

Brigham and Women's Hospital
2007-2018

Clinical Orthopaedics and Related Research
2018

Zimmer Biomet (United States)
2018

Stryker (United States)
2018

Committee on Publication Ethics
2018

Background Negative surgical margins are uncommon for spine sarcomas; hence, adjuvant radiotherapy (RT) may be recommended but tumor dose constrained by spinal cord, nerve, and viscera tolerance. Methods Prospective Phase II clinical trial incorporating high RT. Eligible patients had primary or locally recurrent thoracic, lumbar, and/or sacral spine/paraspinal chordomas sarcomas. Treatment included pre- post-operative photon/proton RT ± radical resection. Results Fifty (29 chordoma, 14...

10.1002/jso.23617 article EN Journal of Surgical Oncology 2014-04-19

Programmed cell death ligand 1 (PDL1, also known as B7H1) is a cell-surface protein that suppresses the cytotoxic CD8(+) T-cell-mediated immune response. PDL1 expression and its clinical relevance in sarcomas are not well understood. Therefore, we sought to measure RNA levels for 38 clinically annotated osteosarcoma tumor samples aimed determine if correlates with features tumor-infiltrating lymphocytes (TIL). Quantitative real-time RT-PCR was optimized 18 lines, of which 5 were derived....

10.1158/2326-6066.cir-13-0224 article EN Cancer Immunology Research 2014-04-22

This is a retrospective review of 49 cases giant cell tumor (GCT) the mobile spine treated surgically.Our goal was to determine which factors influenced local recurrence.GCT benign, locally aggressive that rarely occurs in spine. The management recurrence can be challenging.We performed analysis GCTs managed between 1970 and 2005. Median follow-up 145 months with minimum 2 years or until death. We used Kaplan-Meier method test whether Enneking stage, surgery type, surgical margin had...

10.1097/brs.0b013e3182233ccd article EN Spine 2011-12-17

Spinal chordomas can have high local recurrence rates after surgery with or without conventional dose radiation therapy (RT). Treatment outcomes and prognostic factors high-dose proton-based RT were assessed.The authors conducted a retrospective review of 126 treated patients (127 lesions) categorized according to disease status (primary vs recurrent), resection (en bloc intralesional), margin status, timing.Seventy-one sacrococcygeal, 40 lumbar, 16 thoracic analyzed. Mean was 72.4 GyRBE...

10.3171/2015.3.spine14716 article EN Journal of Neurosurgery Spine 2015-09-04

Background: Current prognostication models for survival estimation in patients with metastatic spine disease lack accuracy. Identifying new risk factors could improve existing models. We assessed associated surgically treated metastases, created a classic scoring algorithm, nomogram, and boosting tested the predictive accuracy of three algorithms at estimating survival. Methods: included 649 from two tertiary care referral centers this retrospective study (2002 to 2014). A multivariate Cox...

10.2106/jbjs.15.00975 article EN Journal of Bone and Joint Surgery 2016-11-02

A retrospective review.The purpose of this study is to report the results high-dose proton based definitive radiotherapy for unresected spinal chordomas.Spine chordoma treated primarily by surgical resection. However, local recurrence rate high. Adjuvant improves control. In certain locations, such as high sacrum, resection may result in significant neurological dysfunction.We retrospectively reviewed 24 patients with newly diagnosed, previously untreated chordomas (core biopsy only; no...

10.1097/brs.0b013e318296e7d7 article EN Spine 2013-04-20

The molecular events in chordoma pathogenesis have not been fully delineated, particularly with respect to copy number changes. Understanding alterations may reveal critical disease mechanisms that could be exploited for tumor classification and therapy. We report the analysis of 21 sporadic chordomas using array comparative genomic hybridization (CGH). Recurrent changes were further evaluated immunohistochemistry, methylation specific PCR, quantitative real-time PCR. Similar previous...

10.1371/journal.pone.0018846 article EN cc-by PLoS ONE 2011-05-13

Myxoid liposarcoma (MLS) has an unusual tendency for extrapulmonary metastasis, particularly to the spine and soft tissues. The objective of this study was determine prevalence spinal treatment outcomes, optimal screening method metastasis in patients with MLS.Data from had metastases were obtained authors' institutional tissue sarcoma database. accuracy which positron emission tomography (PET) scans bone identified metastatic lesions compared magnetic resonance imaging (MRI). Clinical...

10.1002/cncr.22992 article EN Cancer 2007-08-27

Insulin-like growth factor-I receptor (IGF-IR) is an important mediator of tumor cell survival and shows prognostic significance in sarcoma. To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability cyclolignan picropodophyllin (PPP), a member family, to selectively inhibit tyrosine kinase activity IGF-IR several sarcoma line model systems. Of diverse subtypes studied, osteosarcoma lines were found be particularly sensitive...

10.1158/1535-7163.mct-09-0115 article EN Molecular Cancer Therapeutics 2009-07-29

Retrospective case series.To determine the effect of modern surgical and aggressive radiation techniques on outcome in patients with spinal chondrosarcoma.Chondrosarcoma spine presents a difficult challenge. Surgical excision is considered standard care, yet complete not always feasible, rates local control survival are inferior to those reported for extremities.We performed retrospective review cases chondrosarcoma involving above sacrum treated surgically at our institution between 1984...

10.1097/brs.0b013e31823d2143 article EN Spine 2011-10-28

En bloc resection for treatment of sacral tumors is the approach choice patients with resectable who are well enough to undergo surgery, and studies describe patient survival, postoperative complications, recurrence rates associated this treatment. However, most these do not provide patient-reported functional outcomes other than binary metrics bowel bladder function postresection.The purpose study was use validated tools compare quality life based on level in terms (1) physical mental...

10.1007/s11999-015-4361-3 article EN Clinical Orthopaedics and Related Research 2015-05-26

Background: Total en bloc spondylectomy (TES) for the treatment of spinal tumors decreases local recurrence and improves survival compared with intralesional resection. TES approaches vary in both number stages to complete procedure instruments which osteotomies are performed. Methods: We describe a 2-stage technique that employs use threadwire saws. performed retrospective review cases primary solitary metastases involving thoracic or lumbar spine treated our modified at institution between...

10.2106/jbjs.17.00141 article EN Journal of Bone and Joint Surgery 2017-09-06

10.1007/s12178-015-9311-x article EN Current Reviews in Musculoskeletal Medicine 2015-10-22
Coming Soon ...